NKTR: Utang jangka cendhak perusahaan Nektar Therapeutics

Simbol lan logo merek Nektar Therapeutics (NKTR)

The medical sector of Nektar Therapeutics (NKTR) is susceptible to global conflicts that hinder raw material logistics and international patent protection. This daily price chart reflects these complexities, with the debt ratio standing at 0.01. Nektar Therapeutics (NKTR) minimizes biotech risks by developing drugs to combat inflammation and cancer. To compete with industry behemoths and offset the cost of expensive trials, the business is reorganizing its scientific base and seeking strategic allies.

NKTR (Nektar Therapeutics Inc) riwayat Utang jangka cendhak perusahaan saka 04.07.2022 nganti 31.10.2026
Produk sing diprodhuksi Nektar Therapeutics

Controlling issuer liquidity is critical for constructing a resilient portfolio. This metric aggregates all obligations maturing within one year to measure insolvency risk. For Nektar Therapeutics (NKTR), this indicator reflects financial stability while seeking partners for the commercialization of immunotherapy. The trend in total short-term debt allows for an assessment of management's margin of safety. A declining curve minimizes default risk but may signal a reduction in R&D investment.

Analisis pesaing

ARGX - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan BNTX (BioNTech Inc.)|Abivax (ABVX) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan ADMA Corp|PTGX (Protagonist Therapeutics) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan immunovant.com|Kewajiban jangka cendhak perusahaan KNSA (Kiniksa)|GRFS (Grifols SA) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan ADPT (Adaptive Biotechnologies Corp)|Gunggunge utang jangka cendhak Celldex Corp (CLDX)|AUPH - Utang jangka cendhak perusahaan|biocryst.com (BCRX) - Kewajiban jangka cendhak perusahaan|Vera Therapeutics (VERA) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan Dianthus Therapeutics Inc|Kewajiban jangka cendhak perusahaan PHVS|Utang jangka cendhak perusahaan abcellera.com|Utang jangka cendhak perusahaan Tourmaline Bio, Inc. (TRML)|precigen.com - Tanggungan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan PHAR (Pharming Group)|Upstream Bio, Inc. (UPB) - Utang jangka cendhak|ZBIO - Utang jangka cendhak perusahaan|IMNM (Immunome Bio) - Tanggungan utang jangka cendhak perusahaan|GOSS: Utang jangka cendhak perusahaan|Utang jangka cendhak kalvista.com (KALV)|Utang jangka cendhak perusahaan Septerna|Utang jangka cendhak perusahaan Pieris Pharma|Kewajiban jangka cendhak perusahaan SVRA (Savara Corp)|Gedhene kewajiban jangka cendhak RIGL|Utang jangka cendhak perusahaan ANAB (AnaptysBio, Inc.)|Utang jangka cendhak perusahaan astriatx.com ATXS|ENGN - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan RAPT (rapt.com)|JBIO (aerovatetx.com) - Kewajiban jangka cendhak perusahaan|Aclaris Therapeutics, Inc - Silihan lan utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan KYTX|TLSA (tizianalifesciences.com) - Gedhene kewajiban jangka cendhak|Utang jangka cendhak perusahaan CABA|VTYX (Ventyx Biosciences Inc.) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan THTX (Theratechnologies Inc)|Avalo Therapeutics Inc (AVTX) - Utang jangka cendhak|ELDN - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan AGEN (agenusbio.com)|CLYM: Utang jangka cendhak perusahaan|zurabio.com (ZURA) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan aTyr|Adagene Corp - Kewajiban jangka cendhak|Utang jangka cendhak perusahaan IMA|STTK - Utang jangka cendhak|Equillium - Kewajiban jangka cendhak perusahaan|Utang jangka cendhak perusahaan Connect Biopharma Holdings CNTB|IMUX: Kewajiban jangka cendhak perusahaan|Atara Biotherapeutics - Gedhene kewajiban jangka cendhak|IFRX: Utang jangka cendhak perusahaan|XFOR - Gunggunge utang jangka cendhak|ACET (Adicet Bio Inc.) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan Celularity Corp (CELU)|Utang jangka cendhak perusahaan INmune Bio Corp (INMB)|Gunggunge utang jangka cendhak Barinthus Biotherapeutics Corp|Utang jangka cendhak perusahaan Kezar Life Sciences KZR|SABS: Tanggungan utang jangka cendhak perusahaan|AKTX - Utang jangka cendhak perusahaan|ENLV - Utang jangka cendhak perusahaan|QTTB (q32bio.com) - Kewajiban jangka cendhak perusahaan|GOVX: Gedhene kewajiban jangka cendhak|Utang jangka cendhak perusahaan Edesa Biotech, Inc.|IBIO: Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Carisma Therapeutics (CARM)|XTLB: Kewajiban jangka cendhak|Utang jangka cendhak perusahaan BOLT (Bolt Biotherapeutics, Inc.)|Silihan lan utang jangka cendhak perusahaan HCWB|Aptevo - Utang jangka cendhak perusahaan|AIM - Utang jangka cendhak perusahaan|aditxt.com (ADTX) - Utang jangka cendhak perusahaan|GRI Bio Inc - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan XORTX|Kewajiban jangka cendhak perusahaan Vyome Therapeutics (HIND)|Utang jangka cendhak perusahaan REVB|Utang jangka cendhak perusahaan indaptusrx.com (INDP)|Scinai Immunotherapeutics Ltd. - Kewajiban jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan CALI|Affimed Therapeutics - Utang jangka cendhak perusahaan|Gunggunge utang jangka cendhak Allakos Inc. ALLK|hookipapharma.com (HOOK) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan IGM Biosciences|Utang jangka cendhak perusahaan iTeos Therapeutics, Inc.|Kewajiban jangka cendhak perusahaan Ocean Biomedical Inc (OCEA)|Kewajiban jangka cendhak perusahaan TCBP (TC BioPharm (Holdings) PLC)|Utang jangka cendhak perusahaan Third Harmonic Bio Inc (THRD)